Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of HH-003 injection in treated chronic hepatitis B with low-level viremia
CTR20220938Phase 2Completed
- Sponsor
- Huahui Health
- Start
- Apr 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Libevitug in Chronic Hepatitis B (CHB), sponsored by Huahui Health. Started Apr 2022; status: completed.
02
Drugs
Libevitug
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20220938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220938.